Advertisement
CBT vs DOW
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBT is a Hold and DOW is a Hold.
CBT's Indicator enters downward trend
The Aroon Indicator for CBT entered a downward trend on October 14, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 178 similar instances where the Aroon Indicator formed such a pattern. In 121 of the 178 cases the stock moved lower. This puts the odds of a downward move at 68%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBT as a result. In 62 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.
The Moving Average Convergence Divergence Histogram (MACD) for CBT turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CBT's RSI Indicator exited the oversold zone, 18 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBT advanced for three days, in 209 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.523) is normal, around the industry mean (6.363). P/E Ratio (21.975) is within average values for comparable stocks, (209.940). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (1.548). Dividend Yield (0.023) settles around the average of (0.013) among similar stocks. P/S Ratio (1.138) is also within normal values, averaging (48.960).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. CBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
DOW in downward trend: price dove below 50-day moving average on September 17, 2026
DOW moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend. In 31 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 76%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for DOW crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
DOW broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DOW entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on DOW as a result. In 55 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for DOW just turned positive on October 06, 2026. Looking at past instances where DOW's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
Following a +3.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where DOW advanced for three days, in 174 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. DOW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.270) is normal, around the industry mean (10.717). DOW has a moderately high P/E Ratio (75.925) as compared to the industry average of (27.649). DOW's Projected Growth (PEG Ratio) (38.891) is very high in comparison to the industry average of (3.769). Dividend Yield (0.050) settles around the average of (0.044) among similar stocks. P/S Ratio (0.524) is also within normal values, averaging (0.578).
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DOW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
CBT | DOW | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 26 Undervalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 65 | 100 | |
SMR RATING 1..100 | 65 | 93 | |
PRICE GROWTH RATING 1..100 | 58 | 55 | |
P/E GROWTH RATING 1..100 | 6 | 6 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CBT's Valuation (26) in the Industrial Specialties industry is somewhat better than the same rating for DOW (86) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than DOW’s over the last 12 months.
CBT's Profit vs Risk Rating (65) in the Industrial Specialties industry is somewhat better than the same rating for DOW (100) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than DOW’s over the last 12 months.
CBT's SMR Rating (65) in the Industrial Specialties industry is in the same range as DOW (93) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to DOW’s over the last 12 months.
DOW's Price Growth Rating (55) in the Chemicals Specialty industry is in the same range as CBT (58) in the Industrial Specialties industry. This means that DOW’s stock grew similarly to CBT’s over the last 12 months.
DOW's P/E Growth Rating (6) in the Chemicals Specialty industry is in the same range as CBT (6) in the Industrial Specialties industry. This means that DOW’s stock grew similarly to CBT’s over the last 12 months.
| CBT | DOW | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | N/A |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 66% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 67% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 68% | 1 day ago 63% |
| Advances ODDS (%) | 10 days ago 67% | 1 day ago 60% |
| Declines ODDS (%) | 3 days ago 67% | 3 days ago 66% |
| BollingerBands ODDS (%) | N/A | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 66% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBT’s FA Score shows that 2 FA rating(s) are green while DOW’s FA Score has 1 green FA rating(s).
- CBT’s FA Score: 2 green, 3 red.
- DOW’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBT’s TA Score shows that 3 TA indicator(s) are bullish while DOW’s TA Score has 3 bullish TA indicator(s).
- CBT’s TA Score: 3 bullish, 4 bearish.
- DOW’s TA Score: 3 bullish, 6 bearish.
Price Growth
CBT (@Chemicals: Specialty) experienced а -0.34% price change this week, while DOW (@Chemicals: Major Diversified) price change was +5.11% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -2.88%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -4.27%.
The average weekly price growth across all stocks in the @Chemicals: Major Diversified industry was -0.56%. For the same industry, the average monthly price growth was -6.96%, and the average quarterly price growth was -22.74%.
Reported Earning Dates
CBT is expected to report earnings on Nov 02, 2026.
DOW is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Chemicals: Specialty (-2.88% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
@Chemicals: Major Diversified (-0.56% weekly)The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBIF | 25.42 | 0.04 | +0.14% |
| iShares iBonds Oct 2029 Term TIPS ETF (IBIF) | |||
| DHSB | 27.65 | -0.15 | -0.55% |
| Day Hagan Smart Buffer ETF (DHSB) | |||
| FTLS | 77.52 | -0.57 | -0.73% |
| First Trust Long/Short Equity ETF (FTLS) | |||
| NUGY | 11.26 | -0.12 | -1.01% |
| GraniteShares YieldBOOST Gold Miners ETF (NUGY) | |||
| EUV | 22.87 | -1.35 | -5.57% |
| Corgi Lithography & Semiconductor Photonics ETF (EUV) | |||